NCT02822079: DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection |
|
|
| Recruiting | 1 | 32 | US | DNA Plasmid Encoding Interleukin-12 INO-9012, INO-9012, Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Quality of Life Assessment | Mayo Clinic, Inovio Pharmaceuticals, National Cancer Institute (NCI) | Chronic Hepatitis, Hepatitis C Infection | 03/20 | | | |
NCT02772003: DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection |
|
|
| Active, not recruiting | 1 | 33 | US | Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Quality of Life Assessment, Rocakinogene Sifuplasmid, DNA Plasmid Encoding Interleukin-12 INO-9012, INO-9012 | National Cancer Institute (NCI), Inovio Pharmaceuticals | Chronic Hepatitis, Hepatitis C Infection | 03/20 | 03/25 | | |